XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Beginning balance at Dec. 31, 2018 $ 182,596 $ 215 $ 183,290 $ (909)
Balance, shares at Dec. 31, 2018   29,545    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (92,800)   (92,800)  
Unrealized loss on marketable securities, net of income tax expense 6     6
Gain (loss) on derivative securities, effective portion, net of income tax (benefit) expense (223)     (223)
Foreign currency translation adjustment, including income tax expense (benefit) 189     189
Stock-based compensation expense 619 $ 837 (218)  
Common stock issued under equity compensation plan, net of shares withheld for tax payments, in shares   135    
Common stock issued under equity compensation plan, net of shares withheld for tax payments (32) $ (32)    
Common stock issued under employee stock purchase plan, shares   101    
Common stock issued under employee stock purchase plan 241 $ 241    
Balance, shares at Dec. 31, 2019   29,781    
Ending balance at Dec. 31, 2019 90,596 $ 1,261 90,272 (937)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 59,848   59,848  
Unrealized loss on marketable securities, net of income tax expense (4)     (4)
Foreign currency translation adjustment, including income tax expense (benefit) 955     955
Stock-based compensation expense 3,734 $ 3,734    
Common stock issued under equity compensation plan, net of shares withheld for tax payments, in shares   455    
Common stock issued under equity compensation plan, net of shares withheld for tax payments (2,190) $ (2,190)    
Common stock issued under employee stock purchase plan, shares   94    
Common stock issued under employee stock purchase plan 256 $ 256    
Balance, shares at Dec. 31, 2020   30,330    
Ending balance at Dec. 31, 2020 153,195 $ 3,061 150,120 14
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 30,404   30,404  
Unrealized loss on marketable securities, net of income tax expense (4)     (4)
Foreign currency translation adjustment, including income tax expense (benefit) (165)     (165)
Stock-based compensation expense 1,172 $ 1,172    
Common stock issued under equity compensation plan, net of shares withheld for tax payments, in shares   246    
Common stock issued under equity compensation plan, net of shares withheld for tax payments (2,057) $ (2,057)    
Balance, shares at Mar. 31, 2021   30,576    
Ending balance at Mar. 31, 2021 182,545 $ 2,176 180,524 (155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (22,431)   (22,431)  
Unrealized loss on marketable securities, net of income tax expense (4)     (4)
Foreign currency translation adjustment, including income tax expense (benefit) (368)     (368)
Stock-based compensation expense 6,262 $ 6,262    
Common stock issued under equity compensation plan, net of shares withheld for tax payments, in shares   646    
Common stock issued under equity compensation plan, net of shares withheld for tax payments (2,441) $ (2,441)    
Common stock issued under employee stock purchase plan, shares   46    
Common stock issued under employee stock purchase plan 486 $ 486    
Balance, shares at Mar. 31, 2022   31,268    
Ending balance at Mar. 31, 2022 $ 164,049 $ 6,483 $ 158,093 $ (527)